Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22825 | 24282628 | Oxid Med Cell Longev | Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. | 2013 | Details |
| A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
| A22828 | 24277674 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes in obese children. | 2014 | Details |
| A22831 | 24275711 | J Clin Gastroenterol | The prevalence of elevated alanine transaminase and its possible causes in the general Korean population. | 2014 | Details |
| A22832 | 24275555 | Biochim Biophys Acta | Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring. | 2013 | Details |
| A22834 | 24275070 | Toxicol Appl Pharmacol | Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats. | 2013 | Details |
| A22836 | 24274878 | Clin Liver Dis | Host genetic variants in obesity-related nonalcoholic fatty liver disease. | 2013 | Details |
| A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
| A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22845 | 24274867 | Clin Liver Dis | The role of diet and nutritional intervention for the management of patients with NAFLD. | 2013 | Details |
| A22846 | 24274866 | Clin Liver Dis | The role of medications for the management of patients with NAFLD. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22848 | 24274863 | Clin Liver Dis | The impact of obesity on liver histology. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |
| A22854 | 24251709 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22855 | 24251708 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: factors associated with its presence and onset. | 2013 | Details |
| A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
| A22863 | 24268461 | Arch Gerontol Geriatr | Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? | 2013 | Details |
| A22865 | 24267865 | Liver Int | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. | 2013 | Details |
| A22868 | 24265809 | PLoS One | Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family. | 2013 | Details |
| A22869 | 24265237 | Compr Physiol | Steatosis in the liver. | 2013 | Details |
| A22870 | 24264333 | Chest | Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. | 2014 | Details |
| A22871 | 24264040 | Int J Mol Sci | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. | 2013 | Details |
| A22874 | 24262589 | Clin Nutr | Diets and nonalcoholic fatty liver disease: the good and the bad. | 2013 | Details |
| A22880 | 24258517 | Semin Immunopathol | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
| A22888 | 24251213 | Indian J Endocrinol Metab | Correlation between liver fat content with dyslipidemia and Insulin resistance. | 2013 | Details |
| A22889 | 24250305 | Afr Health Sci | Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. | 2013 | Details |
| A22891 | 24249635 | FASEB J | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2013 | Details |
| A22893 | 24246334 | Endocr Pract | Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. | 2014 | Details |
| A22894 | 24239806 | Toxicol Lett | Intrauterine metabolic programming alteration increased susceptibility to non-alcoholic adult fatty liver disease in prenatal caffeine-exposed rat offspring. | 2013 | Details |
| A22896 | 24235062 | World J Pediatr | Type 2 diabetes mellitus in pediatrics: a new challenge. | 2013 | Details |
| A22900 | 24223115 | PLoS One | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A22901 | 24222948 | World J Gastroenterol | Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection. | 2013 | Details |
| A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
| A22904 | 24222095 | Semin Liver Dis | Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. | 2013 | Details |
| A22906 | 24222092 | Semin Liver Dis | The role of gastrointestinal hormones in hepatic lipid metabolism. | 2013 | Details |
| A22918 | 24211299 | Gastroenterology | Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. | 2013 | Details |
| A22923 | 24206666 | Cell Metab | Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. | 2013 | Details |
| A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22926 | 24205731 | Nihon Rinsho | [An inhibitor of intestinal cholesterol transporter]. | 2013 | Details |
| A22928 | 24205128 | PLoS One | Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease. | 2013 | Details |
| A22933 | 24196354 | Int J Mol Sci | Hepatic adverse effects of fructose consumption independent of overweight/obesity. | 2013 | Details |
| A22942 | 24189525 | Sci Rep | Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice. | 2013 | Details |
| A22946 | 24187469 | World J Gastroenterol | Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. | 2013 | Details |
| A22947 | 24187449 | World J Gastroenterol | Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. | 2013 | Details |
| A22949 | 24185692 | Nat Med | Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. | 2013 | Details |
| A22950 | 24184549 | Sci Total Environ | Bisphenol A and cardiometabolic risk factors in obese children. | 2013 | Details |
| A22952 | 24179926 | J Clin Diagn Res | Bardet biedel syndrome: a very rare entity in India. | 2013 | Details |
| A22953 | 24179615 | World J Hepatol | Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH. | 2013 | Details |
| A22954 | 24179614 | World J Hepatol | Lipotoxicity in the liver. | 2013 | Details |
| A22957 | 24176233 | Nutr Res | Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. | 2013 | Details |
| A22959 | 24173405 | Int J Obes (Lond) | Inhibition of adipogenesis in 3T3-L1 cells and suppression of abdominal fat accumulation in high-fat diet-feeding C57BL/6J mice after downregulation of hyaluronic acid. | 2013 | Details |
| A22962 | 24172912 | Eur J Gastroenterol Hepatol | Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A22963 | 30736139 | Expert Rev Endocrinol Metab | Current management of patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22964 | 24170649 | J Am Assoc Nurse Pract | Correlates of nonalcoholic fatty liver among women receiving residential mental health care. | 2012 | Details |
| A22965 | 24167955 | Arch Latinoam Nutr | Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. | 2013 | Details |
| A22967 | 24161963 | Eur J Gastroenterol Hepatol | Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study. | 2014 | Details |
| A22969 | 24160775 | Lipids Health Dis | Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
| A22970 | 24159791 | Klin Med (Mosk) | [Additional advantages of mexicor used in combined therapy of coronary heat disease and diabetes mellitus of 2nd type]. | 2013 | Details |
| A22973 | 24152749 | Nutrients | Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A22975 | 24151364 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. | 2013 | Details |
| A22976 | 24151157 | Pediatr Obes | Alanine aminotransferase and metabolic syndrome in adolescents: the Korean National Health and Nutrition Examination Survey Study. | 2013 | Details |
| A22977 | 24150574 | Aging Clin Exp Res | Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly. | 2013 | Details |
| A22980 | 24140091 | Metabolism | Irisin in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A22981 | 24140006 | Prostaglandins Leukot Essent Fatty Acids | A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats. | 2013 | Details |
| A22983 | 24134913 | Biochem Pharmacol | Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. | 2013 | Details |
| A22984 | 24134687 | Eur J Clin Invest | Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A22989 | 24133660 | Clin Mol Hepatol | Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. | 2013 | Details |
| A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22993 | 24130687 | PLoS One | Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. | 2013 | Details |
| A22995 | 24130212 | Hum Exp Toxicol | Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
| A22996 | 24129399 | Am J Physiol Endocrinol Metab | Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet. | 2013 | Details |
| A22999 | 24124336 | World J Gastroenterol | Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children. | 2013 | Details |
| A23004 | 24119851 | Semin Nephrol | Race and the insulin resistance syndrome. | 2013 | Details |
| A23005 | 24119744 | Zhonghua Gan Zang Bing Za Zhi | [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease]. | 2013 | Details |
| A23006 | 24119413 | BMC Complement Altern Med | Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease. | 2013 | Details |
| A23007 | 24119357 | Acad Radiol | MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. | 2013 | Details |
| A23010 | 24118857 | Liver Int | Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. | 2013 | Details |
| A23011 | 24118743 | Liver Int | Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. | 2013 | Details |
| A23018 | 24114821 | Ann Hepatol | Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells. | 2014 | Details |
| A23019 | 24114819 | Ann Hepatol | Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis. | 2014 | Details |
| A23021 | 24113587 | Int J Mol Sci | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. | 2013 | Details |
| A23022 | 24107103 | Liver Int | Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. | 2013 | Details |
| A23023 | 24106929 | Liver Int | Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease. | 2013 | Details |
| A23029 | 24098813 | PLoS One | Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. | 2013 | Details |
| A23046 | 24080367 | Endocrinology | Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. | 2013 | Details |
| A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23060 | 24072087 | J Clin Res Pediatr Endocrinol | Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2013 | Details |
| A23063 | 24071517 | Mol Cell Endocrinol | Tetramethylpyrazine reduces glucose and insulin-induced activation of hepatic stellate cells by inhibiting insulin receptor-mediated PI3K/AKT and ERK pathways. | 2013 | Details |
| A23064 | 24070151 | Expert Rev Gastroenterol Hepatol | Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review. | 2013 | Details |
| A23068 | 24067262 | Ann Hepatol | Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. | 2014 | Details |
| A23077 | 24064253 | Clin Nutr | Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. | 2013 | Details |
| A23081 | 24059726 | Mini Rev Med Chem | Hepatic diseases related to triglyceride metabolism. | 2013 | Details |
| A23093 | 24045866 | Am J Physiol Endocrinol Metab | The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis. | 2013 | Details |
| A23097 | 24042449 | Nat Rev Gastroenterol Hepatol | The global NAFLD epidemic. | 2013 | Details |
| A23107 | 24036369 | Int Immunopharmacol | Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. | 2013 | Details |
| A23109 | 24035445 | Metabolism | Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. | 2013 | Details |